
Cleancard
Cleancard is a YC Summer 2023 (S23) company. Based in San Francisco, CA, USA. Team of 16.
About Cleancard
Summary
Cleancard develops at-home urine-based tests for cancer detection, combining synthetic biology and AI to deliver lab-grade diagnostic results in 30 minutes. The platform targets individuals who would otherwise rely on clinical lab work, replacing the need for a facility visit with a single home sample. A broader platform approach allows the same urine sample to be used for tracking multiple biomarkers and conditions over time.
Go-to-market
Cleancard targets consumers directly with a self-administered home test, removing clinicians and labs from the initial diagnostic step.
From the Y Combinator listing
Making cancer detection as easy as a pregnancy test
We are combining synthetic biology and artificial intelligence to make cancer detection as easy as a pregnancy test. Cleancard's mission is to bring lab-grade diagnostics into the comfort of your home. Our novel method enables robust diagnostics and biomarker tracking from the urine. We are currently developing fully at-home, 30-minute tests for cancer using this methodology. We are constantly expanding the number of conditions we can detect from a single sample with our platform technology.
Facts
- Healthcare / Healthcare -> Diagnostics
- San Francisco, CA, USA
- 16
- Active
- Growth
Founders (2)
- Luca Springer
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works